inserted into the intrathecal (IT) space and the tip advanced to the level of T12. After minimum of 2 days, the rat was placed vertical on a tilt table and three micturition cycles were recorded under light isoflurane anesthesia (1.2 -2%). Subsequently, an IT injection of lidocaine was used to suppress the micturition reflex. The pressure at which overflow incontinence started was recorded followed by manually evacuating the bladder and filling it to 50% of its capacity. Then the LPP was assessed using the Crede maneuver (CM).
inserted into the intrathecal (IT) space and the tip advanced to the level of T12. After minimum of 2 days, the rat was placed vertical on a tilt table and three micturition cycles were recorded under light isoflurane anesthesia (1.2 -2%). Subsequently, an IT injection of lidocaine was used to suppress the micturition reflex. The pressure at which overflow incontinence started was recorded followed by manually evacuating the bladder and filling it to 50% of its capacity. Then the LPP was assessed using the Crede maneuver (CM).
RESULTS: IT catheter insertion success rate was~90%. Position of the IT catheter was confirmed by injection of lidocaine causing transient paraplegia in awake rat. Cystometry under light isoflurane anesthesia produced full micturition cycles with mean maximal pressure of 30.9 cm/H2O, (min. 18.6, max. 37.4 ) and mean intermicturition oscillatory pressure of 8.0 cm/ H2O (min. 4.6, max. 11.9) . IT administration of lidocaine completely blocked micturition contractions. The intravesical pressure at which overflow incontinence ensued was 29.6 cm/ H2O (min. 24.0, max. 34.6) . LPP using the CM was 31.0 cm/ H2O (min. 18.5, max. 36.3) . CONCLUSIONS: In low concentration, isoflurane anesthesia preserves continence, bladder contraction and coordinated function between the bladder and sphincter. This makes it appropriate for testing LPP. Isoflurane anesthesia allows placing the animal vertical on the tilt table, and IT injection of lidocaine blocks micturition. The learning curve for IT catheter placement is steep. In most cases, the intravesical pressure at which overflow incontinence coincided closely with the LPP measured using the CM. This experimental design allows repeated evaluation of LPP in a single animal. 
Source of

INTRODUCTION AND OBJECTIVES:
Confronted by the limitations of current biomaterials applied in bladder augmentation and urgent clinic needs of alternatives for traditional enterocystoplasty, this study compared the performance of a novel asymmetric bilayer chitosan scaffold with conventional bladder acellular matrix graft (BAMG) in the purpose to assess the feasibility of this strategy as a supplement or replacement for current bladder biomaterials.
METHODS: Twenty-four 4-week-old male Sprague-Dawley rats were randomly divided into 3 groups which were subjected to augmentation cystoplasty with BAMG, bilayer chitosan scaffolds and sham operation respectively, with 8 rats in each group. At the timepoints of 21 days and 70 days post-implantation, basic epidemiological data, morphological, histological (hematoxylin and eosin, Masson's trichrome and immunofluorescence analyses) and functional evaluations were carried out to compare bladder regeneration comprehensively.
RESULTS: Bilayer chitosan scaffold exhibited an excellent combination of mechanical strength and flexibility, with minimal fibrosis and contracture after integrated into bladder defect. All rats survived during the experimental period, recovered to normal activities and were able to void spontaneously without significant difference in body weight, except that one rat in BAMG group (70 days group) died of urinary ascites within first week post-op. It was proved that bilayer chitosan scaffold had a better performance in both histological staining and morphological analyses of cystography. While the de novo cytokeratin positive urothelia appeared more abundant in BAMG group than chitosan group when compared to control group, the regeneration of asmooth muscle actin (a-SMA) and SM22-a positive smooth muscle bundles, NeuN positive neural buttons, the mean number of CD31 positive vessels were more favorable in chitosan group than BAMG group, but still did not catch up with the normal level. The mean diameter of CD31 positive vessels revealed that the neo-vessels in BAMG and chitosan group were relatively immature. For both BAMG and chitosan groups, urodynamic analyses demonstrated that the bladder compliance was improved after augmentation, and the interval void cycle time, void volume and bladder capacity were elevated correspondingly, while the peak void pressure of BAMG was exceptionally high.
CONCLUSIONS: The asymmetric bilayer chitosan scaffold displayed a high potential in facilitating defect regeneration in the rat model of bladder augmentation, which still need further modifications in enhancing the regeneration of urothelia, accelerating re-innervation and promoting neo-angiogenesis. RESULTS: 84 patients were enrolled with a mean age of 62.6AE13.5 years. 50/84 patients (59.5%) suffered from NP, and 50/84 patients (59.5%) had decreased BC. No gender difference in the incidence of NP and reduced BC were found. Patients with a reduced BC and NP presented a significant larger mean BC (p ¼ 0.002) at night-time when compared to day-time and the highest number of nocturia episodes (3.2AE1.6); patients with a normal BC and with NP presented a significant larger mean and maximum BC at night-time (p ¼ 0.033 and p ¼ 0.016, respectively) when compared to day-time (Table 1 ). In patients with reduced BC and without NP no significant variations in BC was observed between day-time and night-time (Table 1) . On multivariate Vol. 197, No. 4S, Supplement, Tuesday, May 16, 2017 THE JOURNAL OF UROLOGY â e1247 analysis BMI (OR: 1.28 per unit, 95%CI: 1.04-1.58; p ¼ 0.019) and severe nocturia (6.26, 95%CI: 1.71-22.92, p ¼ 0.006) were independent predictive factors for NP, while only severe nocturia (3.77, 95%CI: 1.20-11.83, p ¼ 0.023) was an independent predictive factor for a reduced BC. CONCLUSIONS: Patients with NP presented a different BC between day-time and night-time. Severe nocturia (!3 episodes per night) predicts the presence of NP and a reduced BC. Our data suggest that in patients with severe nocturia both conditions should be considered and managed.
Source of
Source of Funding: none
MP94-08 GROUP III METABOTROPIC GLUTAMATE RECEPTOR-MEDIATED REGULATION OF MICTURITION REFLEX IN URETHANE-ANESTHETIZED RATS
Masashi Honda*, Yusuke Kimura, Bunya Kawamoto, Panagiota Tsounapi, Katsuya Hikita, Yonago, Japan; Shogo Shimizu, Takahiro Shimizu, Motoaki Saito, Nankoku, Japan; Atsushi Takenaka, Yonago, Japan INTRODUCTION AND OBJECTIVES: The modulatory actions of glutamate, the main excitatory neurotransmitter in the central nervous system, are exerted via activation of metabotropic glutamate receptors (mGluRs). Eight distinct mGluRs (mGluR1-8) have been classified into three groups (I-III) based on their sequence homology. Group III mGluRs (mGluRIII; mGluR4, mGluR6, mGluR7 and mGluR8) are widely distributed throughout the central nervous system. However, it is unknown whether mGluRIII plays a role in the regulation of neural mechanisms controlling the micturition reflex. In the present study, we assessed whether L-(+)-2-amino-4-phosphonobutyric acid (L-AP4), a selective mGluRIII agonist, affects the micturition reflex in urethaneanesthetized rats.
METHODS: Adult female Sprague-Dawley rats weighing 238 to 261 g were used. Continuous cystometrograms (CMG, 0.04 ml/min infusion rate) were performed in two groups of urethane-anesthetized rats. A group of 24 rats was used for intracerebroventricular administration of 1-10 mg of L-AP4 via a catheter inserted into the lateral ventricle. Using a stereotaxic micro-injector, a 30 gauge needle attached to a 10 ml Hamilton syringe was inserted into the lateral ventricle and single doses of drugs were administered in a volume of 2 ml during 2 minutes. In the second group of 24 rats, 1-10 mg of L-AP4 were administered intrathecally via an intrathecal catheter. Intrathecal injections were made through a polyethylene-10 (PE-10) catheter positioned at the level of the L6-S1 spinal cord. A PE-10 intrathecal catheter was implanted using isoflurane anesthesia 3 days before the experiments. Cystometric parameters were recorded and compared before and after drug administration.
RESULTS: Intracerebroventricular administration of L-AP4 at doses of 1, 3 and 10 mg (n¼8 per dose) increased intercontraction intervals in a dose dependent fashion to 117.1 AE 12.3%, 132.5 AE 10.5% and 137.1 AE 15.6% of the control value, respectively (p <0.01), but did not affect residual urine or baseline pressure at any of the doses tested. Intrathecal administration of L-AP4 at doses of 1, 3 and 10 mg (n¼8 per dose) also increased intercontraction intervals in a dose dependent fashion to 125.3 AE 8.2%, 136.9 AE 7.1% and 142.7 AE 12.6% of the control value, respectively (p <0.01), but did not affect residual urine or baseline pressure at any of the doses tested.
CONCLUSIONS: The results of our study indicate that in urethane-anesthetized rats activation of mGluRIII can inhibit the micturition reflex at supraspinal and spinal sites. Thus, mGluRIII could be a potential target for the treatment of bladder dysfunction, such as overactive bladder.
Source of Funding: None
MP94-09
ROLE OF THE SEROTONERGIC SYSTEM IN URETHRAL CONTINENCE REFLEXES DURING SNEEZING IN RATS
Takahisa Suzuki*, Pittsburgh, PA; Takahiro Shimizu, Nankoku, Japan; Joombeom Kwon, Eiichiro Takaoka, Shun Takai, Nobutaka Shimizu, Pittsburgh, PA; Naoki Wada, Asahikawa, Japan; Seiichiro Ozono, Hamamatsu, Japan; Naoki Yoshimura, Pittsburgh, PA INTRODUCTION AND OBJECTIVES: The spinal serotonergic pathways are reportedly involved in the control of urethral continence reflexes that prevent stress urinary incontinence (SUI). We previously demonstrated that serotonin (5HT) receptor subtypes, 5HT 1A and 5HT 2C , respectively reduce and enhance the urethral continence reflex during sneezing in rats. However, because there are other multiple excitatory and inhibitory 5HT receptors, the overall effects of the 5HT system on the urethral function are not well elucidated. Therefore, in this study, we examined the effects of 5HT depletion induced by p-chlorophenylalanine (PCPA) that inhibits 5HT synthesis, on urethral baseline activity and reflex contractions during sneezing in rats.
METHODS: We used female 12-week-aged Sprague-Dawley rats, which were divided into two groups; vehicle-administered (Normal, n ¼ 6) and PCPA-administered groups (PCPA, n ¼ 5). PCPA (200 mg/ kg/day) was administered intraperitoneally for two days. Thereafter, using a microtransducer-tipped catheter inserted to the mid-urethra, we assessed urethral baseline pressure (UBP) and the amplitude of urethral responses during sneezing (AURS) under urethane anesthesia. UBP was determined from a plateau section of pressure recordings just before inducing sneezing, which was induced by intranasal stimulation with a whisker. AURS values were measured as the urethral maximal pressure change from baseline during sneezing. To evaluate induced sneeze intensity, abdominal pressure during sneezing (Pabd) was also measured via an intraabdominal balloon catheter. All data are shown in cmH 2 O.
RESULTS: UBP and AURS were both significantly decreased in the PCPA group (17.8 and 36.7) compared to the Normal group (31.1 and 71.8), respectively (Figure) . There was no statistical difference in Pabd between two groups (Normal; 18.2, PCPA; 28.3).
CONCLUSIONS: This result indicates that activation of the serotonergic system contributes to maintaining the urethral baseline activity and the urethral continence reflex during stress conditions such as sneezing, which are reportedly attributable to contractions of smooth and striated urethral sphincter muscles, respectively. Also, 5HTdepleted rats could be a suitable SUI model to investigate the effects of 5HT receptor subtype-selective agonists on urethral continence function.
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